ClinicalTrials.gg
Sign In

Esthesioneuroblastoma, Olfactory clinical trials

The registry lists 75 studies for Esthesioneuroblastoma, Olfactory across more than 10 countries. 11 are recruiting or about to start. 9 of them are mainly about Esthesioneuroblastoma, Olfactory (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Esthesioneuroblastoma, Olfactory studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
52
Recruiting
11
Withdrawn
5
Terminated
4
Active, not recruiting
2
Status unknown
1

Phase

Phase 1
29
Phase 2
23
Phase 3
8
Phase 4
1
Early Phase 1
1

Where

United States
60
Canada
3
Italy
1
Switzerland
1
United Kingdom
1
Netherlands
1

Who runs them

National Cancer Institute (NCI) (14) · Memorial Sloan Kettering Cancer Center (5) · Alliance for Clinical Trials in Oncology (4) · Vanderbilt-Ingram Cancer Center (4) · Case Comprehensive Cancer Center (3) · University of Arizona (2) · M.D. Anderson Cancer Center (2) · Vanderbilt University (2)

What is being tested here

Drugs under test in Esthesioneuroblastoma, Olfactory studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin105
Etoposide103
Gemcitabine103
Cyclophosphamide102
Zanzalintinib101
Enasidenib101
AMG 757101
Lead PB-212101
Olaparib101
Lutetium Lu 177 dotatate101

Drug classes tested here Antimetabolites 1 open · Tyrosine kinase inhibitors (TKIs) 1 open · Alkylating agents 1 open · Antimitotic agents 7 · Angiogenesis inhibitors 4

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 11 Esthesioneuroblastoma, Olfactory studies recruiting now, 5 (45%) set no upper age limit and 1 (9%) stop at 75 or younger. 3 (27%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
103 (27%)3 (27%)
1811 (100%)11 (100%)
3010 (91%)10 (91%)
4010 (91%)10 (91%)
5010 (91%)10 (91%)
6510 (91%)10 (91%)
7510 (91%)10 (91%)
8510 (91%)10 (91%)

Across all 75 studies, recruiting or not: 4% stop at 75 or younger and 3% at 65; 9% take children; 1% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 75. Browse all 75 → or search them.